According to the weekly comprehensive price quotation and transaction information of the national carbon market, the comprehensive price quotation of the national carbon market this week is: the highest price is 102.03 yuan/ton, and the lowest price is 98.95 yuan/ton, and the closing price is 0.20% lower than last Friday. This week, the transaction volume of the listing agreement was 4,455,200 tons, with a turnover of 443,893,910.63 yuan; The volume of bulk agreement transactions was 35,748,795 tons, with a turnover of 353,449,4051.32 yuan. This week, the total turnover of the national carbon emission quota was 40,203,995 tons, with a total turnover of 397,877,961.95 yuan. From January 1 to December 13, 2024, the volume of carbon emission quota in the national carbon market was 169,736,665 tons, with a turnover of 162,864,7748.47 yuan. As of December 13, 2024, the cumulative turnover of carbon emission quotas in the national carbon market was 611,359,276 tons, with a cumulative turnover of 412,056,282,67.75 yuan. (National Carbon Trading)Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.Twenty-five pilot banks in Shenzhen have opened a total of 64,000 cross-border wealth management accounts. The reporter was informed that by the end of November 2024, 25 pilot banks in Shenzhen had opened a total of 64,000 cross-border wealth management accounts, with a total amount of cross-border receipts and payments of 42.74 billion yuan, accounting for 48.1% and 44.2% of Guangdong-Hong Kong-Macao Greater Bay Area respectively.
Zhejiang Securities Regulatory Bureau: issued a warning letter to Hangzhou Huayu Frequent Private Equity Fund Co., Ltd. On December 13, the website of Zhejiang Securities Regulatory Bureau issued a decision on taking measures to issue a warning letter to Hangzhou Huayu Frequent Private Equity Fund Co., Ltd. After investigation, the company has the following behaviors in carrying out private equity fund business: 1. There are irregularities in the appropriate materials of fund products managed by investors, and the company has not made further audit; Second, the risk control review process of related party transactions is not perfect. The above behavior violates the first paragraph of Article 4 of the Interim Measures for the Supervision and Administration of Private Investment Funds (Order No.105 of the CSRC). According to the provisions of Article 33 of the Interim Measures for the Supervision and Administration of Private Investment Funds, Zhejiang Securities Regulatory Bureau decided to issue a warning letter to the company and record it in the integrity file of the securities and futures market.Pacific Securities: Goldwind Technology's performance is expected to achieve rapid growth, with the first "buy" rating. Pacific Securities Research Report pointed out that with the profit recovery of wind turbine business and the contribution of wind farm investment and development and wind power service business, Goldwind Technology's (002202.SZ) performance is expected to achieve rapid growth. The first coverage gives a "buy" rating. Goldwind Technology has ranked first in the domestic wind power market for 13 consecutive years since 2011; However, in recent years, under the strong competitive pressure of wind turbine enterprises after the second line, their market share has declined. In the future, with the increase of market concentration, Goldwind Technology, as a leader, is expected to increase its share. At the end of the third quarter of 2024, the company's external order volume was 41.38GW, and sufficient in-hand order volume supported its share increase.The Kuala Lumpur Composite Index of Malaysia closed up 0.4% at 1,608.75.
Director of the International Energy Agency (IEA): Geothermal energy is suitable for providing a large amount of stable energy for data centers. The IEA said on Friday that shale drilling technology, which has led to a sharp increase in oil and gas production, has also stimulated the development of geothermal energy. In theory, geothermal energy can provide a stable power source equivalent to the total demand of India and the United States. Fatih Birol, director of the International Energy Agency, said after the agency released its first report on geothermal energy that geothermal energy is suitable for providing a large amount of stable energy for data centers. Birol said: "One of the demands for geothermal energy is the demand for electricity in data centers. The demand for data centers in the United States is great, and they need all-weather electricity, which makes geothermal very suitable. " Birol said that unlike renewable energy such as wind energy and solar energy, geothermal energy can be a sustainable energy source, but it is still in its infancy and needs a lot of investment and support from the government. The incoming Trump administration said it would promote more oil and gas drilling and hoped to reduce the green energy plan, but Birol saw no reason not to increase the use of geothermal energy. According to the data of the International Energy Agency, by 2050, the global geothermal heating may increase to 800 GW, accounting for 15% of the global demand growth, and the annual output is equivalent to the current total demand of the United States and India. According to the report of the International Energy Agency, global investment will exceed $1 trillion by 2035 and $2.8 trillion by 2050, of which about 75% will be invested in power generation facilities.Market News: It is reported that Morgan Stanley will buy a mortgage loan from Santander Bank, worth about 900 million euros.Tianyu Co., Ltd.: The subsidiary company plans to select the tenth batch of national centralized drug procurement, and the wholly-owned subsidiary company Zhejiang Nuode Pharmaceutical Co., Ltd. plans to select the product of sitagliptin metformin tablets (II) and sitagliptin phosphate tablets to select the tenth batch of national centralized drug procurement organized by the National Drug Joint Procurement Office.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14